Classifying aging as a disease in the context of ICD-11

Frontiers in Genetics

Volumn 6, Issue NOV, 2015, Pages

  Zhavoronkov, Alex ^a,b   Bhullar, Bhupinder ^c  

^a The Biogerontology Research Foundation   (United Kingdom)

^b Insilico Medicine Inc   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Aging; Biogerontology; Disease classification; ICD 10; ICD 11; QALY; Task force; WHO

Indexed keywords

AGING; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; ICD-10; ICD-11; LIFE EXPECTANCY; QUALITY ADJUSTED LIFE YEAR;

EID: 84954559411     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00326     Document Type: Article

References (115)

1. Aguilar-Olivos, N. E., Oria-Hernandez, J., Chavez-Tapia, N. C., Uribe, M., and Mendez-Sanchez, N. (2015). The role of epigenetics in the progression of non-alcoholic fatty liver disease. Mini Rev. Med. Chem. 15, 1187-1194.
2. Aliper, A. M., Csoka, A. B., Buzdin, A., Jetka, T., Roumiantsev, S., Moskalev, A., et al. (2015). Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging (Albany NY) 7, 26-37.
3. American Medical Association. (1961). "Standard nomenclature of diseases and operations, " in National Conference on Medical Nomenclature (U.S.), eds R. J. Plunkett and A. C. Hayden (New York: American Medical Association).
4. Ardeljan, D., and Chan, C. C. (2013). Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog. Retin. Eye Res. 37, 68-89. doi: 10.1016/j.preteyeres.2013.07.003
5. Benn, P., Cuckle, H., and Pergament, E. (2013). Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol. 42, 15-33. doi: 10.1002/uog.12513
6. Bennett, G. A., Cobb, S., Jacox, R., Jessar, R. A., and Ropes, M. W. (1956). Proposed diagnostic criteria for rheumatoid arthritis. Bull. Rheum. Dis. 7, 121-124.
7. Bircher, J. (2005). Towards a dynamic definition of health and disease. Med. Health Care Philos. 8, 335-341. doi: 10.1007/s11019-005-0538-y
8. Blagosklonny, M. V. (2013). Selective anti-cancer agents as anti-aging drugs. Cancer Biol. Ther. 14, 1092-1097. doi: 10.4161/cbt.27350
9. Blumenthal, H. T. (1993). The aging-disease dichotomy is alive, but is it well? J. Am. Geriatr. Soc. 41, 1272-1273. doi: 10.1111/j.1532-5415.1993.tb07314.x
10. Blumenthal, H. T. (2003). The aging-disease dichotomy: true or false? J. Gerontol. A Biol. Sci. Med. Sci. 58, 138-145. doi: 10.1093/gerona/58.2.M138
11. Bruunsgaard, H., Pedersen, M., and Pedersen, B. K. (2001). Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8, 131-136. doi: 10.1097/00062752-200105000-00001
12. Bulterijs, S., Hull, R. S., Bjork, V. C., and Roy, A. G. (2015). It is time to classify biological aging as a disease. Front. Genet 6:205. doi: 10.3389/fgene.2015.00205
13. Butler, R. N., Sprott, R., Warner, H., Bland, J., Feuers, R., Forster, M., et al. (2004). Biomarkers of aging: from primitive organisms to humans. J. Gerontol. A Biol. Sci. Med. Sci. 59, B560-B567. doi: 10.1093/gerona/59.6.B560
14. Callahan, D., and Topinkova, E. (1998). Is aging a preventable or curable disease? Drugs Aging 13, 93-97. doi: 10.2165/00002512-199813020-00001
15. Caplan, A. L. (2005). Death as an unnatural process. Why is it wrong to seek a cure for aging? EMBO Rep 6, S72-S75. doi: 10.1038/sj.embor.7400435
16. Centers for Disease Control. (2004). Instructions for Completing the Cause-of-Death Section of the Death Certificate. Available at: http://www.dhh.state.la.us/assets/oph/Center-RS/vitalrec/leers/Death/CDC_Info/CDCCompletingCauseofDeath_InjuryPoisoning.pdf
17. Check Hayden, E. (2015). Anti-ageing pill pushed as bona fide drug. Nature 522, 265-266. doi: 10.1038/522265a
18. Chiu, R. W., Cantor, C. R., and Lo, Y. M. (2009). Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet. 25, 324-331. doi: 10.1016/j.tig.2009.05.004
19. Cieslik, K. A., Taffet, G. E., Carlson, S., Hermosillo, J., Trial, J., and Entman, M. L. (2011). Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. J. Mol. Cell Cardiol. 50, 248-256. doi: 10.1016/j.yjmcc.2010.10.019
20. Corino, V. D., Matteucci, M., and Mainardi, L. T. (2007). Analysis of heart rate variability to predict patient age in a healthy population. Methods Inf. Med. 46, 191-195.
21. Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., et al. (2010). Sarcopenia: european consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39, 412-423. doi: 10.1093/ageing/afq034
22. Cullen, W. (1816). A Synopsis of Nosology by William Cullen. Translated from the Latin, with references to the best authors who have written since his time, by John Thompson. Thomas Dobson.
23. Deleidi, M., Jaggle, M., and Rubino, G. (2015). Immune aging, dysmetabolism, and inflammation in neurological diseases. Front. Neurosci. 9:172. doi: 10.3389/fnins.2015.00172
24. De Rosa, M., Pace, U., Rega, D., Costabile, V., Duraturo, F., Izzo, P., et al. (2015). Genetics, diagnosis and management of colorectal cancer (Review). Oncol Rep. 34, 1087-1096. doi: 10.3892/or.2015.4108
25. Dhahbi, J. M. (2014). Circulating small noncoding RNAs as biomarkers of aging. Ageing Res. Rev. 17, 86-98. doi: 10.1016/j.arr.2014.02.005
26. Donmez, G., and Guarente, L. (2010). Aging and disease: connections to sirtuins. Aging Cell 9, 285-290. doi: 10.1111/j.1474-9726.2010.00548.x
27. Elmenshawy, A. R., Machin, D. R., and Tanaka, H. (2015). A rise in peak performance age in female athletes. AGE 37, 1-8. doi: 10.1007/s11357-015-9795-8
28. Faragher, R. G. A. (2015). Should we treat ageing as a disease? The consequences and dangers of miscategorisation. Front. Genet. 6:171. doi: 10.3389/fgene.2015.00171
29. Federal Interagency Forum on Aging-Related Statistics. (2012). Older Americans 2012: Key Indicators of Well-Being. Federal Interagency Forum on Aging-Related Statistics. Hyattsville, USA.
30. Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., et al. (2011). Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249-256. doi: 10.1016/j.jamda.2011.01.003
31. First, M. B., Reed, G. M., Hyman, S. E., and Saxena, S. (2015). The development of the ICD-11 clinical descriptions and diagnostic guidelines for mental and behavioural disorders. World Psychiatry 14, 82-90. doi: 10.1002/wps.20189
32. Force, W. I. T. (1980). Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br. Heart J. 44, 672-673. doi: 10.1136/hrt.44.6.672
33. Franceschi, C., Capri, M., Monti, D., Giunta, S., Olivieri, F., Sevini, F., et al. (2007). Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92-105. doi: 10.1016/j.mad.2006.11.016
34. Garber, K. (2008). A mid-life crisis for aging theory. Nat. Biotechnol. 26, 371-374. doi: 10.1038/nbt0408-371
35. Gems, D. (2015a). The aging-disease false dichotomy: understanding senescence as pathology. Front. Genet 6:212. doi: 10.3389/fgene.2015.00212
36. Gems, D. (2015b). The aging-disease false dichotomy: understanding senescence as pathology. Front. Genet. 6:212. doi: 10.3389/fgene.2015.00212
37. Glasser, M. (1986). Toward a unified theory of disease: understanding the aging process. Med. Hypotheses 20, 385-391. doi: 10.1016/0306-9877(86)90098-8
38. Hatse, S., Brouwers, B., Dalmasso, B., Laenen, A., Kenis, C., Schoffski, P., et al. (2014). Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: correlation with chronological age but not with fitness/frailty status. PLoS ONE 9:e110644. doi: 10.1371/journal.pone.0110644
39. Hefti, F. F., and Bales, R. (2006). Regulatory issues in aging pharmacology. Aging Cell 5, 3-8. doi: 10.1111/j.1474-9726.2006.00193.x
40. Helling, B. A., and Yang, I. V. (2015). Epigenetics in lung fibrosis: from pathobiology to treatment perspective. Curr. Opin. Pulm. Med. 21, 454-462. doi: 10.1097/MCP.0000000000000191
41. Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., and Weissert, W. G. (2000). Willingness to pay for a quality-adjusted life year: in search of a standard. Med. Decis. Making 20, 332-342. doi: 10.1177/0272989X0002000310
42. Horvath, S. (2013). DNA methylation age of human tissues and cell types. Genome Biol. 14, R115. doi: 10.1186/gb-2013-14-10-r115
43. Horvath, S., Erhart, W., Brosch, M., Ammerpohl, O., Von Schonfels, W., Ahrens, M., et al. (2014). Obesity accelerates epigenetic aging of human liver. Proc. Natl. Acad. Sci. U.S.A. 111, 15538-15543. doi: 10.1073/pnas.1412759111
44. Horvath, S., and Levine, A. J. (2015). HIV-1 infection accelerates age according to the epigenetic clock. J. Infect. Dis. doi: 10.1093/infdis/jiv277 [Epub ahead of print].
45. Huber, M., Knottnerus, J. A., Green, L., Van Der Horst, H., Jadad, A. R., Kromhout, D., et al. (2011). How should we define health? Bmj 343, d4163. doi: 10.1136/bmj.d4163
46. Kapetanaki, M. G., Mora, A. L., and Rojas, M. (2013). Influence of age on wound healing and fibrosis. J. Pathol. 229, 310-322. doi: 10.1002/path.4122
47. Katschnig, H. (2010). Are psychiatrists an endangered species? Observations on internal and external challenges to the profession. World Psychiatry 9, 21-28. doi: 10.1002/j.2051-5545.2010.tb00257.x
48. Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., et al. (2014). Geroscience: linking aging to chronic disease. Cell 159, 709-713. doi: 10.1016/j.cell.2014.10.039
49. Kulminski, A., Ukraintseva, S. V., Akushevich, I., Arbeev, K. G., Land, K., and Yashin, A. I. (2007). Accelerated accumulation of health deficits as a characteristic of aging. Exp. Gerontol. 42, 963-970. doi: 10.1016/j.exger.2007.05.009
50. Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W., Mastroeni, D., et al. (2015). The epigenetics of aging and neurodegeneration. Prog. Neurobiol. 131, 21-64. doi: 10.1016/j.pneurobio.2015.05.002
51. Le Couteur, D. G., Mclachlan, A. J., Quinn, R. J., Simpson, S. J., and De Cabo, R. (2012). Aging biology and novel targets for drug discovery. J. Gerontol. A Biol. Sci. Med. Sci. 67, 168-174. doi: 10.1093/gerona/glr095
52. Lo, Y. M. (2013). Non-invasive prenatal testing using massively parallel sequencing of maternal plasma DNA: from molecular karyotyping to fetal whole-genome sequencing. Rep. Biomed. Online 27, 593-598. doi: 10.1016/j.rbmo.2013.08.008
53. Lombard, D. B., Chua, K. F., Mostoslavsky, R., Franco, S., Gostissa, M., and Alt, F. W. (2005). DNA repair, genome stability, and aging. Cell 120, 497-512. doi: 10.1016/j.cell.2005.01.028
54. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013). The hallmarks of aging. Cell 153, 1194-1217. doi: 10.1016/j.cell.2013.05.039
55. Lord, C., and Jones, R. M. (2012). Annual research review: re-thinking the classification of autism spectrum disorders. J. Child Psychol. Psychiatry 53, 490-509. doi: 10.1111/j.1469-7610.2012.02547.x
56. Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2013). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128. doi: 10.1016/S0140-6736(12)61728-0
57. Macaskill, W. (2015). Doing Good Better: Effective Altruism and How You Can Make a Difference. New York: Penguin Publishing Group.
58. Makarev, E., Cantor, C., Zhavoronkov, A., Buzdin, A., Aliper, A., and Csoka, A. B. (2014). Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions. Aging (Albany NY) 6, 1064-1075.
59. Mannick, J. B., Del Giudice, G., Lattanzi, M., Valiante, N. M., Praestgaard, J., Huang, B., et al. (2014). mTOR inhibition improves immune function in the elderly. Sci. Transl. Med. 6, 268ra179. doi: 10.1126/scitranslmed.3009892
60. Marengoni, A., Angleman, S., Melis, R., Mangialasche, F., Karp, A., Garmen, A., et al. (2011). Aging with multimorbidity: a systematic review of the literature. Ageing Res. Rev. 10, 430-439. doi: 10.1016/j.arr.2011.03.003
61. Mateos-Aierdi, A. J., Goicoechea, M., Aiastui, A., Fernandez-Torron, R., Garcia-Puga, M., Matheu, A., et al. (2015). Muscle wasting in myotonic dystrophies: a model of premature aging. Front. Aging Neurosci. 7:125. doi: 10.3389/fnagi.2015.00125
62. Mehrez, A., and Gafni, A. (1989). Quality-adjusted life years, utility theory, and healthy-years equivalents. Med. Decis. Making 9, 142-149. doi: 10.1177/0272989X8900900209
63. Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., et al. (2013). Proinflammatory cytokines, aging, and age-related diseases. J. Am. Med. Dir. Assoc. 14, 877-882. doi: 10.1016/j.jamda.2013.05.009
64. Mitnitski, A., and Rockwood, K. (2015). Aging as a process of deficit accumulation: its utility and origin. Interdiscip Top Gerontol. 40, 85-98. doi: 10.1159/000364933
65. Montecino-Rodriguez, E., Berent-Maoz, B., and Dorshkind, K. (2013). Causes, consequences, and reversal of immune system aging. J. Clin. Invest. 123, 958-965. doi: 10.1172/JCI64096
66. Moreno-Villanueva, M., Capri, M., Breusing, N., Siepelmeyer, A., Sevini, F., Ghezzo, A., et al. (2015). MARK-AGE standard operating procedures (SOPs): a successful effort. Mech. Ageing Dev. doi: 10.1016/j.mad.2015.03.007 [Epub ahead of print].
67. Moriyama, I. M., Loy, R. M., and Robb-Smith, A. H. T. (2011). History of the Statistical Classification of Diseases and Causes of Death. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Hyattsville, USA.
68. Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos, V., Bauer, J., Bhasin, S., et al. (2011). Sarcopenia with limited mobility: an international consensus. J. Am. Med. Dir. Assoc. 12, 403-409. doi: 10.1016/j.jamda.2011.04.014
69. Moskalev, A. A., Aliper, A. M., Smit-Mcbride, Z., Buzdin, A., and Zhavoronkov, A. (2014). Genetics and epigenetics of aging and longevity. Cell Cycle 13, 1063-1077. doi: 10.4161/cc.28433
70. Murray, C. J. L., and Lopez, A. D. (1996a). "Estimating causes of death: new methods and global and regional application for 1990, " in Global Burden of Disease and Injury Series. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020, eds C. J. L. Murray and A. D. Lopez (Boston: Harvard School of Public Health, on behalf of the World Health Organization and the World Bank), 117-200.
71. Murray, C. J. L., and Lopez, A. D. (1996b). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston: Harvard School of Public Health, on behalf of the World Health Organization and the World Bank.
72. Muscaritoli, M., Anker, S. D., Argiles, J., Aversa, Z., Bauer, J. M., Biolo, G., et al. (2010). Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics." Clin. Nutr. 29, 154-159. doi: 10.1016/j.clnu.2009.12.004
73. Nakamura, S., Kawai, K., Takeshita, Y., Honda, M., Takamura, T., Kaneko, S., et al. (2012). Identification of blood biomarkers of aging by transcript profiling of whole blood. Biochem. Biophys. Res. Commun. 418, 313-318. doi: 10.1016/j.bbrc.2012.01.018
74. Nakata, N., Wang, Y., and Bhatt, S. (2010). Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age. Prenat. Diagn. 30, 198-206. doi: 10.1002/pd.2434
75. National Conference on Nomenclature of Disease. (1933). "A standard classified nomenclature of diseases, " in National Conference on Nomenclature of Disease, ed. H. Logie. (New York: Commonwealth Fund).
76. Nepomnyashchaya, Y. N., Artemov, A. V., Roumiantsev, S. A., Roumyantsev, A. G., and Zhavoronkov, A. (2013). Non-invasive prenatal diagnostics of aneuploidy using next-generation DNA sequencing technologies, and clinical considerations. Clin. Chem. Lab. Med. 51, 1141-1154. doi: 10.1515/cclm-2012-0281
77. Neufeld-Kaiser, W. A., Cheng, E. Y., and Liu, Y. J. (2015). Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center. BMC Med. 13:129. doi: 10.1186/s12916-015-0374-8
78. Nilsson, O., and Baron, J. (2005). Impact of growth plate senescence on catch-up growth and epiphyseal fusion. Pediatr. Nephrol. 20, 319-322. doi: 10.1007/s00467-004-1689-4
79. Nutrition Business Journal. (2015). NBJ's Supplement Business Report 2015. Available at: http://newhope360.com/site-files/newhope360.com/files/uploads/2015/05/2015_SupplementReport_TOC.pdf
80. Office for National Statistics. (2010). Guidance for Doctors Completing Medical Certificates of Cause of Death in England and Wales [Online]. [accessed August 06, 2015].
81. Rattan, S. I. (2014). Aging is not a disease: implications for intervention. Aging Dis. 5, 196-202. doi: 10.14336/AD.2014.0500196
82. Renauer, P., Coit, P., and Sawalha, A. H. (2015). Epigenetics and vasculitis: a comprehensive review. Clin. Rev. Allergy Immunol. doi: 10.1007/s12016-015-8495-6 [Epub ahead of print].
83. Reznek, L. (1987). The Nature of Disease. London, UK: Routledge & Kegan Paul.
84. Ries, W. (1976). The relations between aging and disease. Z. Gesamte Inn. Med. 31, 85-89.
85. Robb-Smith, A. (1969). A history of the college's 6. nomenclature of diseases: its preparation. J. R. Coll. Physicians 3, 341-358.
86. Rockwood, K., Mitnitski, A., Song, X., Steen, B., and Skoog, I. (2006). Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J. Am. Geriatr. Soc. 54, 975-979. doi: 10.1111/j.1532-5415.2006.00738.x
87. Salive, M. E. (2013). Multimorbidity in older adults. Epidemiol. Rev. 35, 75-83. doi: 10.1093/epirev/mxs009
88. Sanders, J. L., Ding, V., Arnold, A. M., Kaplan, R. C., Cappola, A. R., Kizer, J. R., et al. (2014). Do changes in circulating biomarkers track with each other and with functional changes in older adults? J. Gerontol. A Biol. Sci. Med. Sci. 69, 174-181. doi: 10.1093/gerona/glt088
89. Saracci, R. (1997). The World Health Organisation needs to reconsider its definition of health. Bmj 314, 1409-1410. doi: 10.1136/bmj.314.7091.1409
90. Sarkar, D., and Fisher, P. B. (2006). Molecular mechanisms of aging-associated inflammation. Can. Lett. 236, 13-23. doi: 10.1016/j.canlet.2005.04.009
91. Scott, C. T., and DeFrancesco, L. (2015). Selling long life. Nat. Biotech. 33, 31-40. doi: 10.1038/nbt.3108
92. Scully, J. L. (2004). What is a disease? EMBO Rep. 5, 650-653. doi: 10.1038/sj.embor.7400195
93. Shamir, L. (2015). Composite aging markers can be used for quantitative profiling of aging. Gerontology doi: 10.1159/000433466 [Epub ahead of print].
94. Shindyapina, A. V., Mkrtchyan, G. V., Gneteeva, T., Buiucli, S., Tancowny, B., Kulka, M., et al. (2014). Mineralization of the connective tissue: a complex molecular process leading to age-related loss of function. Rejuvenation Res. 17, 116-133. doi: 10.1089/rej.2013.1475
95. Shock, N., Greulich, R., Andres, R., Arenberg, D., Costa, P., Lakatta, E., et al. (1984). Normal Human Aging: The Baltimore Longitudinal Study of Aging. Washington, DC: Government Printing Office.
96. Sprott, R. L. (2010). Biomarkers of aging and disease: introduction and definitions. Exp. Gerontol. 45, 2-4. doi: 10.1016/j.exger.2009.07.008
97. Tikkinen, K. A., Leinonen, J. S., Guyatt, G. H., Ebrahim, S., and Jarvinen, T. L. (2012). What is a disease? Perspectives of the public, health professionals and legislators. BMJ Open 2, e001632. doi: 10.1136/bmjopen-2012-001632
98. Treede, R. D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., et al. (2015). A classification of chronic pain for ICD-11. Pain 156, 1003-1007. doi: 10.1097/j.pain.0000000000000160
99. Twiss, P., Hill, M., Daley, R., and Chitty, L. S. (2014). Non-invasive prenatal testing for Down syndrome. Semin Fetal Neonatal Med. 19, 9-14. doi: 10.1016/j.siny.2013.10.003
100. van Deursen, J. M. (2014). The role of senescent cells in ageing. Nature 509, 439-446. doi: 10.1038/nature13193
101. Vellas, B. J., Albarede, J. L., and Garry, P. J. (1992). Diseases and aging: patterns of morbidity with age; relationship between aging and age-associated diseases. Am. J. Clin. Nutr. 55, 1225s-1230s.
102. WHO. (1994). Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Geneva: WHO.
103. Williams, T. F. (1987). Aging or disease? Clin. Pharmacol. Ther. 42, 663-665. doi: 10.1038/clpt.1987.217
104. World Health Organization. (1948). Constitution of the World Health Organization. Geneva: World Health Organization.
105. World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
106. World Health Organization. (2006). History of the Development of the ICD. Geneva: World Health Organization.
107. World Health Organization. (2011). International Statistical Classification of Diseases and Related Health Problems. 10th Revision, Edition 2010. Geneva: World Health Organization.
108. Wu, I. C., Lin, C. C., and Hsiung, C. A. (2015). Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. Biomedicine (Taipei) 5, 1. doi: 10.7603/s40681-015-0001-1
109. Yashin, A. I., Arbeev, K. G., Kulminski, A., Akushevich, I., Akushevich, L., and Ukraintseva, S. V. (2007). Cumulative index of elderly disorders and its dynamic contribution to mortality and longevity. Rejuvenation Res. 10, 75-86. doi: 10.1089/rej.2006.0500
110. Zhang, W. G., Zhu, S. Y., Bai, X. J., Zhao, D. L., Jian, S. M., Li, J., et al. (2014). Select aging biomarkers based on telomere length and chronological age to build a biological age equation. Age (Dordr) 36, 9639. doi: 10.1007/s11357-014-9639-y
111. Zhavoronkov, A. (2013). The Ageless Generation: How Advances in Biomedicine Will Transform the Global Economy. New York: Palgrave Macmillan.
112. Zhavoronkov, A. (2015). Longevity expectations in the pension fund, insurance, and employee benefits industries. Psychol. Res. Behav. Manag. 8, 27-39. doi: 10.2147/PRBM.S75440
113. Zhavoronkov, A., Buzdin, A. A., Garazha, A. V., Borisov, N. M., and Moskalev, A. A. (2014). Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs. Front. Genet. 5:49. doi: 10.3389/fgene.2014.00049
114. Zhavoronkov, A., Debonneuil, E., Mirza, N., and Artyuhov, I. (2012). Evaluating the impact of recent advances in biomedical sciences and the possible mortality decreases on the future of health care and Social Security in the United States. Pensions Int. J. 17, 241-251. doi: 10.1057/pm.2012.28
115. Zhavoronkov, A., and Litovchenko, M. (2013). Biomedical progress rates as new parameters for models of economic growth in developed countries. Int. J. Environ. Res. Public Health 10, 5936-5952. doi: 10.3390/ijerph10115936